Drug companies' patient-assistance programs--helping patients or profits?

N Engl J Med. 2014 Jul 10;371(2):97-9. doi: 10.1056/NEJMp1401658.

Author

David H Howard¹

Affiliation

¹ From the Department of Health Policy and Management, the Department of Economics, and the Winship Cancer Institute, Emory University, Atlanta.

PMID: 25006717
DOI: 10.1056/NEJMp1401658

No abstract available

MeSH terms

Cost Sharing*
Drug Costs
Drug Industry / economics*
Financial Support*
Humans
Insurance, Health / economics*
Insurance, Health / legislation & jurisprudence
Prescription Fees*
United States
United States Dept. of Health and Human Services